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Abstract
Increasing evidence shows that the host gut microbiota might be involved in the immunological cascade that culminates with the formation of tissue granulomas underlying the pathophysiology of hepato-intestinal schistosomiasis. In this study, we investigated the impact of
Schistosoma mansoni infection on the gut microbial composition and functional potential of
both wild type and microbiome-humanized mice. In spite of substantial differences in microbiome composition at baseline, selected pathways were consistently affected by parasite
infection. The gut microbiomes of infected mice of both lines displayed, amongst other features, enhanced capacity for tryptophan and butyrate production, which might be linked to
the activation of mechanisms aimed to prevent excessive injuries caused by migrating parasite eggs. Complementing data from previous studies, our findings suggest that the host gut
microbiome might play a dual role in the pathophysiology of schistosomiasis, where intestinal bacteria may contribute to egg-associated pathology while, in turn, protect the host from
uncontrolled tissue damage.

Author summary
Schistosomiasis is a neglected tropical disease affecting >250 million people worldwide.
Causative agents are parasitic worms of the genus Schistosoma, that inhabit the small

PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0010878 October 24, 2022

1 / 25

PLOS NEGLECTED TROPICAL DISEASES

European Nucleotide Archive (ENA) with the study
accession number PRJEB40471.
Funding: This research was funded by grants
awarded by the Wellcome Trust [grant 206194] to
MB and GR, the Fundación Alfonso Martı́n
Escudero to AC and the University of Cambridge to
CC. KAS is the grateful recipient of a PhD
scholarship by the Cambridge Trust. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors declare that they
have no competing interests

The gut microbiome of Schistosoma-infected wildtype vs. microbiota-humanised mice

blood vessels irrigating the gut and urinary bladder. Adult schistosomes lay their eggs that
make their way to the environment by piercing the intestinal or urinary bladder wall to
reach the host feces and urine, respectively. Schistosoma infections are associated with
substantial alterations of gut bacterial communities of both naturally infected humans and
experimentally infected mice. Intestinal bacteria are also hypothesized to contribute to the
intestinal pathology caused by migrating parasite eggs. Here, we investigated the impact
of schistosome infection on the composition and function of gut bacteria inhabiting wild
type and microbiome-humanized laboratory rodents. Schistosome colonization was consistently associated with an increased (predicted) ability of gut bacteria to synthetize tryptophan and butyrate, both of which are known to promote intestinal barrier function by
preventing translocation of potentially harmful bacteria into the circulation. Our findings
suggest that intestinal bacteria may exert both harmful and protective roles during schistosomiasis, and provide a basis for the development of much needed novel and sustainable
strategies for management and control of this neglected disease.

Introduction
Schistosomiasis, caused by blood flukes of the genus Schistosoma, is a neglected tropical disease
affecting the world’s poorest communities [1]. Globally, >250 million people are infected with
at least one of the three major species that infect humans—S. mansoni, S. japonicum and S.
haematobium—mostly in regions of sub-Saharan Africa and focal areas of America, the Middle East and Asia [1]. Adult male and female worms dwell in copula, first in the portal system,
and then, in the mesenteric or pelvic veins of their hosts. Fertilized females lay eggs that, following a migration through the lining of small venules, pierce the wall of the intestine (S. mansoni and S. japonicum) or the bladder (S. haematobium) to be released with the host feces or
urine, respectively [1]. Subsequently, when eggs reach the freshwater environment, they hatch
ciliated miracidia that seek out and infect snail intermediate hosts [1]. Inside the snail, the parasites undergo a phase of asexual reproduction, i.e., from mother and daughter sporocysts to
free-living infectious cercariae that leave the snail to swim and seek the definitive mammalian
host. The cercariae penetrate the host skin, shed their tails and become schistosomula that
enter the circulation and migrate through the lungs, heart and liver, where they further
develop into male and female worm pairs. Between 3 and 4 weeks post-infection, paired adult
worms migrate to the mesenteric venules (S. mansoni and S. japonicum) or the venous plexus
of the urinary bladder (S. haematobium) and begin to release hundreds of eggs per day [1].
The pathophysiology of acute schistosomiasis is mainly associated with parasite eggs becoming
trapped in various organs and tissues (i.e., the intestine and liver, or the urinary bladder) and
subsequent formation of inflammatory granulomas containing immune cells (alternatively
activated macrophages, granulocytes, Th2 and B cells) and extracellular matrix [2]. During the
chronic phase of infection, granulomas shrink and are replaced by fibrous tissue, that often
compromises the function of affected organs [1].
The genesis of Schistosoma egg-induced granulomas is the result of a finely regulated crosstalk between egg-secreted antigens and host immunity [2,3]. However, over the last few years,
evidence has emerged of the likely contribution of a third player–the host gut microbiota–in
the cascade of immunological events that culminate with the formation of tissue granulomas
[4–8]. First, in a seminal study conducted in murine schistosomiasis [4], administration of
broad-spectrum antibiotics and antimycotics resulted in substantially decreased intestinal
inflammation and granuloma development. In the same study, lymphocyte preparations from
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mesenteric lymph nodes retrieved from microbiota-depleted mice showed reduced production
of IFN-γ and IL-10 when exposed to S. mansoni secreted egg antigen, thus indicating that gut
resident bacteria may influence schistosome-specific immunity [4]. Supporting the hypothesis
of a key role of the host gut microbiota in the pathophysiology of schistosomiasis, we previously detected dramatic alterations in the gut microbial profiles of mice during acute patent
infection by S. mansoni compared with uninfected controls [5]; these alterations included substantially decreased and increased gut bacterial alpha- and beta diversity, respectively, as well
as changes in the relative abundances of populations of microbes with putative roles in host
immune-regulatory and/or inflammatory responses [5]. We therefore speculated that such
changes, indicative of dysbiosis and accompanying egg migration across the gut wall and consequent immunopathology, might contribute to the pathophysiology of hepato-intestinal
schistosomiasis [5]. In a subsequent study, we attempted to investigate the translational significance of these findings by characterizing the gut microbial profiles of microbiota-humanized
[human-microbiota-associated (HMA)] and wild type (WT) mice prior to and following infection with S. mansoni [8]. High-throughput sequencing of the bacterial 16S rRNA gene revealed
profound differences between the microbial profiles of these cohorts at baseline, with the gut
microbiota of HMA being characterized by low microbial alpha diversity, expanded populations of Proteobacteria and absence of lactobacilli compared to WT rodents [8]. Of note, whilst
S. mansoni infection was associated with a significant decrease in gut microbial alpha diversity
in both rodent lines, analysis of bacterial taxa whose relative abundances were altered following worm colonization revealed substantial dissimilarities between HMA and WT mice [8].
Interestingly, significantly higher worm and egg burdens were recovered from HMA vs. WT at
the end of the experiment [8]. Based on this observation, we hypothesized that the structure
and function of the host baseline gut microbiome (i.e., prior to infection) might play a key role
in the complex network of interactions between schistosome parasites, the host and its
immune system. Whilst data from these studies represent a step forward in our current understanding of these relationships, the microbiota profiling techniques applied thus far (i.e., bacterial culturing followed by colony counting and bacterial 16S rRNA gene amplicon sequencing)
[4,5,8] do not permit explorations of schistosomiasis-associated changes in gut bacterial populations beyond genus-level taxonomic mapping. Determining differences in gut microbial
communities between schistosome-infected and -uninfected HMA and WT mice at species
level, and evaluating the relative contribution of each community member to the overall pool
of functional genes, are nonetheless pivotal. This knowledge is likely to unveil mechanisms
underlying crosstalk between host, parasite and microbiome during schistosome infection.
In this study, we undertake high-throughput shotgun metagenomics sequencing of the gut
microbiome of HMA and WT mice to provide a high-resolution map of the functional potential of gut bacterial communities established in these mouse lines. Furthermore, we investigate
changes in the composition and functional potential of these communities following experimental infection with S. mansoni. We show that, despite profound differences in compositional and functional profiles between the two murine lines, parasite colonization induced
partially overlapping alterations in bacterial metabolic capacity, including up-regulation of
pathways linked to L-tryptophan biosynthesis and fermentation to short chain fatty acids
(SCFAs).

Results and discussion
Gut bacterial profiles differ between WT and HMA mice
Whole genome sequencing (WGS) of fecal DNA extracts from both S. mansoni-infected (hereafter referred to as ‘Sm+’) and uninfected (‘Sm-’) WT and HMA mice yielded 228.03�106 ±
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31.13�106 (mean ± standard deviation) reads per sample, while no-DNA template negative
controls generated 10.56�103 ± 13.27�103 reads (S1 Fig). Mean base count per sample prior to
and following quality filtering and removal of host sequences did not yield significant differences between mouse lines, nor between infection groups within each line (S1 Fig).
Taxonomic profiling of filtered metagenomic data identified a total of 449 bacterial species
across samples encompassing both WT (418 species) and HMA mice (363 species); these
belonged to 187 genera, of which 38 and 18 were unique to WT and HMA, respectively (S1
Table and S2 Fig). Substantial differences in both bacterial species composition and corresponding relative abundances were observed between the gut microbiomes of WT and HMA
mice (Figs 1, S2 and S3), with HMA gut bacterial communities clustering separately from
those of WT by Principal Coordinates Analysis (PCoA) (Fig 2A), as previously reported [8].
Moreover, microbial beta diversity in WT was significantly higher than that in HMA (cf. Fig
2A; ANOSIM: R = 1, p<0.001), likely due to differences in breeding and housing conditions
between these rodent lines (i.e., specific-pathogen-free environment for WT vs. isolation for
HMA).
Species richness and alpha diversity (Shannon index) in the gut microbiome of WT were
significantly higher than those in HMA (t-test p = 0.002, t = 3.362, df = 26; and p<0.0001,
t = 6.450, df = 26, respectively) (Fig 2B). This observation is in accordance with our previous
marker-gene-based work, where significantly higher bacterial alpha diversity was observed in
the gut microbiota of WT compared to HMA mice [8], a finding tentatively attributed to a
likely failure of selected human gut microbes to colonize the mouse gastrointestinal (GI) tract
[8]. Moreover, according to previous observations [8], substantial differences were detected in
the relative abundances of predominant taxa in the GI tracts of WT and HMA (S2 Fig). For
instance, several Bacteroides species, including B. cellulosilyticus, B. vulgatus, B. dorei and B.
thetaiotaomicron, amongst others, predominated in HMA, whereas B. acidifaciens was significantly more abundant in WT mice. These differences, along with the absence of individual
bacterial species (and/or genera) in the gut of WT or HMA mice, might impact the overall
functional potential of the microbiomes of these mice, as well as of the microbiota-mediated
immune modulation [9]. A striking example is represented by the genus Lactobacillus, whose
members were only detected in the gut of WT animals (S1 Table). These bacteria are common
inhabitants of mouse and human GI tracts, and their relative abundance frequently increases
following microbial transfers between mice [10,11]; however, previous studies have reported a
failure of members of Lactobacillaceae to engraft the colons of HMA mice following fecal
material transplant of human feces containing lactobacilli [12]. Most lactobacilli produce lactate, that may be further fermented by other gut bacteria into butyrate, a SCFA with antiinflammatory properties [13,14]. In addition, selected species and strains of Lactobacillus are
responsible for activation of mechanisms of innate immunity in the host GI tract via toll-like
receptor (TLR)-dependent and -independent pathways [15,16]. Interestingly, our previous
data revealed higher S. mansoni infection burdens in HMA vs. WT mice, which led us to
hypothesize the occurrence of a link between host baseline microbiota composition and susceptibility to infection [8]. Whilst attributing these observations to the absence of lactobacilli
in the HMA gut is currently unwarranted, our data point toward this bacterial group as a
potential target for future mechanistic studies aimed to elucidate these interactions.

The gut bacterial metagenomes of WT and HMA mice feature distinct
functional profiles
We then performed functional annotations of gut metagenome data of both Sm+ and Sm- WT
and HMA mice using established bioinformatics pipelines (see Materials and Methods).
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Fig 1. Gut bacterial community composition. Hierarchical clustering of gut bacterial communities of wild type (WT) and human-microbiota-associated
(HMA) mice (columns) grouped according to Pearson correlation between species relative abundances (rows) and explanatory variables indicated at the top of
the figure [i.e., experiment, mouse line, infection status and infection burden (EPG = eggs per gram)]. Dark lines on the heatmap separate major clusters in
both axes.
https://doi.org/10.1371/journal.pntd.0010878.g001

Principal Component Analysis (PCA) applied to pathway abundance data separated the gut
microbiomes of WT and HMA mice into two distinct clusters along PC1 (Fig 2C) [supported
by Canonical Correspondence Analysis (CCA; p = 0.001, F = 64.9)], thus revealing profound
differences in the overall functional profiles of bacterial communities colonizing the gut of
each murine line.
A total of 289 metabolic pathways were identified by HUMAnN3 (https://huttenhower.sph.
harvard.edu/humann/) in at least five samples of WT and/or HMA mice; of these, 244 and 276
were detected in the metagenomes of WT and HMA, respectively, and analyzed further (S4
Fig and S2 Table). Thirteen pathways were solely detected in the microbiomes of WT; these
included, amongst others, ‘Bifidobacterium shunt’ (P124-PWY; a fermentation pathway for
production of lactate and the SCFA acetate), ‘L-glutamate degradation IV’ (PWY-4321) and
‘spermine and spermidine degradation I’ (PWY-6117) (S2 Table). Notably, bacterial species
contributing to pathways solely identified in WT remained mostly unclassified, except for Lactobacillus reuteri, which was associated with ‘L-glutamate degradation IV’ (PWY-4321),
‘superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)’ (PWY-5910) and
‘mevalonate pathway I (eukaryotes and bacteria)’ (PWY-922) (S2 Table). HUMAnN relies on
the MetaPhlAn tool (https://huttenhower.sph.harvard.edu/metaphlan/) to identify bacterial
organisms present in a given metagenome [17]. The MetaPhlAn algorithm estimates microbial
taxa abundance based on the coverage of clade-specific marker genes that are present in all
strains of a given species, thus representing a powerful strategy to generate unambiguous
markers for genetic characterization of metagenomic species [17]. Such an approach, however,
favors the identification of species with several strains for which complete genomes are available; thus, taxonomic annotation using this approach is likely to lead to the identification of a
smaller number of species compared with WGS read-mapping against reference genomes in
the GenBank database, as the latter contains sequences from several species with incomplete
genome assemblies.
The 45 pathways uniquely identified in the microbiomes of HMA included eight superpathways for the biosynthesis of menaquinones [e.g., ‘superpathway of menaquinol-8 biosynthesis
I’ (PWY-5838) and ‘superpathway of menaquinol-11 biosynthesis’ (PWY-5897)], several pathways involved in the synthesis of cell wall and outer membrane components [‘peptidoglycan
biosynthesis IV (Enterococcus faecium)’ (PWY-6471), ‘peptidoglycan biosynthesis V (β-lactam
resistance)’ (PWY-6470), ‘peptidoglycan biosynthesis II (staphylococci)’ (PWY-5265), ‘superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis’ (PWY-7328) and
‘superpathway of dTDP-glucose-derived O-antigen building blocks biosynthesis’ (PWY7317)], and pathways for the degradation/utilization of carbohydrates, including ‘trehalose
degradation V’ (PWY-2723), ‘glycogen degradation I’ (GLYCOCAT-PWY), ‘starch degradation III’ (PWY-6731) and ‘glucose and glucose-1-phosphate degradation’ (GLUCOSE1PMETAB-PWY). Similar to WT mice, bacterial species contributing to HMA-unique pathways
remained largely unclassified (S2 Table).
Differences between the gut bacterial profiles of WT vs. HMA are likely to underpin profound functional dissimilarities between these communities. Other external factors that had
shaped the composition of the donor microbiome inoculum prior to administration to HMA
recipients (e.g., diet, feeding patterns and metabolic requirements, among others) might also
contribute to these functional differences [18]. However, it is important to point out that such
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discrepancies may not be conclusively associated to the differences in S. mansoni infection
burdens observed in WT vs. HMA mice [cf. 8], as similar end-products of microbiome metabolism could be generated via distinct biological pathways. For instance, the ‘Bifidobacterium
shunt’ pathway detected in WT mice might be associated with enhanced ability to produce lactate/acetate (and thus, butyrate) [13,14]; however, several HMA-unique pathways for carbohydrates degradation (see above) might result in higher rates of pyruvate biosynthesis and, in
turn, of SCFA production [19].

Schistosoma mansoni infection is associated with altered gut bacterial
community structure and species composition in both WT and HMA mice
We subsequently focused on characterizing the effect(s) of S. mansoni infection on the gut bacterial community structure of each WT and HMA. Using PCoA, gut bacterial communities of
both WT and HMA clustered by infection status, although only HMA Sm+ and Sm- samples
grouped separately along the PCoA1 axis (Fig 3A and 3B). Microbial beta diversity was significantly higher across Sm+ samples of both WT (ANOSIM: R = 0.361, p<0.004) and HMA
(ANOSIM: R = 0.651, p<0.002) compared to their uninfected counterparts. In contrast, Shannon index was unaltered following infection of either line, although a significant decrease in
gut bacterial richness was observed in HMA at 50 days post S. mansoni colonization (t-test
p = 0.014, t = 2.864, df = 12) (S5 Fig). Infections by Schistosoma spp. had been associated with
significantly decreased gut bacterial richness and alpha diversity, and linked to local inflammation and tissue damage caused by migrating parasite eggs [5,7]. Differences in infection burdens [cf. 5] or Schistosoma species [cf. 7] used in these previous studies might hold partially
accountable for this discrepancy. Nonetheless, our published 16S rRNA gene amplicon
sequencing data had also revealed significant reductions in alpha diversity in WT and HMA
mice infected with S. mansoni [8]. Hence, our current observations might be indicative of the
fact that marker gene data may lead to an overestimation of the impact of the infection on gut
bacterial alpha diversity.
Hierarchical clustering of WT and HMA gut microbiomes grouped HMA samples according to infection status, while WT Sm+ and Sm- samples remained partially intermingled;
moreover, ordination of infected samples according to infection burdens [i.e., worm counts
and/or eggs per gram (EPG) of liver] was not observed in either mouse line (Fig 1). In order to
gain insights into species whose abundances were altered following S. mansoni infection, the
relative abundances of identified bacteria were compared between Sm+ and Sm- mice of each
line. Significant differences in bacterial species abundance associated with infection status
were detected in both WT and HMA mice by Linear Discriminant Analysis Effect Size (LEfSe)
and confirmed by Mann-Whitney U test; these alterations encompassed members of the genera Bacteroides, Parabacteroides, Alistipes and Barnesiella (Fig 3C and S3 Table), which had
been previously reported to change in response to S. mansoni infection in WT and/or HMA
mice in targeted metagenomics studies [5,6,8]. Furthermore, strong significant correlations
(i.e., Pearson’s r � |0.8|, p<0.001) were observed between selected bacterial species significantly impacted by infection (cf. Fig 3C) and parasite burdens (i.e., worm counts and/or EPG
of liver; cf. [8]) in the two mouse lines (S4 Table).
Both Bacteroides and Alistipes harbor species with known anti-inflammatory properties,
whilst expansions of selected members of each genus have been also linked to selected inflammatory conditions. For instance, B. acidifaciens, a species expanded in the gut of WT Sm+
mice, has been reported to overgrow following IL-22 blockage in a mouse model of chronic
Salmonella gastroenteritis, ultimately leading to exacerbated intestinal inflammation [20].
Additional studies, however, have demonstrated protective effects of this bacterial species
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Fig 3. Alterations in gut microbial community composition of wild type (WT) and human-microbiota-associated (HMA) mice associated
with Schistosoma mansoni infection. Principal Coordinates Analyses (PCoA) of microbial community profiles of WT (A) and HMA (B) mice
infected with S. mansoni (Sm+) and uninfected controls (Sm-). (C) Bacterial species displaying significant differences in abundance between
infected and uninfected samples of each WT and HMA mice, based on Linear Discriminant Analysis Effect Size (LEfSe).
https://doi.org/10.1371/journal.pntd.0010878.g003

against liver inflammation and allergic asthma that may be mediated by the production of
SCFAs [21,22]. Remarkably, expansion of B. acidifaciens and increased butyrate production
were linked to enhanced gut barrier integrity and function. Similarly, while several Alistipes
species have been linked to the gut of healthy and diseased individuals [23], oral gavage with
A. finegoldii (significantly expanded in WT Sm+) was associated with protection against colitis
in mice [24].
Some Bacteroides species, whose abundances were reduced upon S. mansoni infection in
HMA, have been reported to exert anti-inflammatory effects in rodent models of intestinal
inflammation, and/or when administered as probiotics; e.g., B. uniformis [25,26], and B. cellulosilyticus [27]. However, intriguingly, these changes were accompanied by a significant expansion of P. goldsteinii (Fig 3C), whose relative abundance had been negatively correlated with
fecal levels of lipocalin-2 (a marker of intestinal inflammation) in mice genetically susceptible
to colitis [28]. This association suggested a protective effect of P. goldsteinii against colitis,
which was tentatively attributed to the ability of this bacteria to produce SCFAs [29], as well as
to promote regulatory IL-10 and reduce proinflammatory IL-1β and intestinal permeability
[30,31]. Expansions of the genus Parabacteroides were previously linked to S. mansoni infection in both HMA and WT mice [8]. However, our current data show that, unlike in HMA,
expansion of this genus in the gut of WT Sm+ mice was mainly linked to P. distasonis (Fig 3C),
whose roles in health and disease may vary depending on bacterial strain- and host-related factors [32].
Additionally, previously unreported expansions of the Lactobacillus species L. reuteri and L.
johnsonii were observed in the gut microbiomes of WT Sm+ mice compared with uninfected
counterparts (Fig 3C). Alterations of GI populations of lactobacilli have been described in several rodent models of helminth colonization, including mice infected with S. mansoni
[reviewed in 33]. In particular, a transient expansion of Lactobacillus spp. was reported in
mice prior to the onset of egg laying by S. mansoni, that was however not maintained post-egg
laying [5]. Likewise, our previously published targeted metagenomics data did not reveal significant alterations in the abundance of Lactobacillus post egg-laying [8]. Hence, current data
pointing towards expanded populations of selected lactobacilli following S. mansoni infection
might be indicative of a role of these bacteria in the pathophysiology of schistosomiasis, and
are thus worth exploring. Indeed, the roles of lactobacilli in mediating protection against GI
inflammation have been extensively described [34,35]. For instance, L. reuteri exerts protective
effects against chemically-induced experimental colitis via reduced leukocyte recruitment,
platelet-mediated inflammation and bacterial translocation [36,37]; similarly, L. johnsonii has
been demonstrated to exert protective anti-inflammatory activity against bacterial colitis in
mice [38]. Moreover, the occurrence of a mutualistic relationship between gut lactobacilli and
the GI nematode Heligmosomoides polygyrus was proposed in a seminal study showing that
supplementation of L. taiwanensis promoted chronic helminth establishment via Treg expansion in rodent mesenteric lymph nodes [39]. Whether L. reuteri and/or L. johnsonii play a role
in regulating host immunity and/or local inflammation in hepato-intestinal schistosomiasis is
yet to be determined. However, remarkably, loss of lactobacilli in antibiotic-treated mice recolonized by co-housing with S. mansoni-infected rodents resulted in increased susceptibility to
DSS-induced colitis, when compared to microbiota-depleted mice co-housed with uninfected
controls [6].
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Altogether, observed changes in the composition of the gut microbiota at species-level resolution suggest that several bacteria might be selectively expanded in the gut of WT and HMA
mice following S. mansoni infection, and assist with protection against egg-mediated tissue
damage and inflammation. However, given that the impact of S. mansoni-induced intestinal
pathology and immune environment on the protective effects of some of these bacteria is difficult to assess [20], and that such protective effects might be associated with specific strains of
these bacterial species [32], this hypothesis remains to be thoroughly tested. Indeed, not only
determining individual species whose abundances are affected by S. mansoni infection, but
also their contribution to intestinal protection/damage is essential to gain new insights onto
the role(s) of gut bacteria in the pathophysiology of schistosomiasis.

Schistosomiasis is associated with alterations of the gut microbial
functional profiles of WT and HMA mice
The gut bacterial metagenomes of HMA and WT mice were clustered according to their predicted metabolic profiles by pathway abundance data, stratified by known and unclassified
organisms. PCA revealed marked differences between the gut bacterial functional profiles of
HMA Sm- and HMA Sm+, that were supported by CCA (F = 5.29, p = 0.001; Fig 4A). In contrast, WT samples clustered by experiment (S6 Fig), rather than by infection status (Fig 4A),
with minimal overlap. Accordingly, CCA yielded significant differences in WT gut microbial
metabolic profiles according to experiment (F = 3.05, p = 0.002), but not to infection (F = 1.49,
p = 0.128).
Metabolic pathways detected in at least 5 metagenomes of either HMA or WT were analyzed for correlation with S. mansoni infection by MaAsLin2 and LEfSe on unstratified data.
The complete lists of metabolic pathways associated with the gut metagenomes of Sm+ and
Sm- of each WT and HMA, by MaAsLin2 and/or LEfSe, are available from S5 and S6 Tables,
respectively. A total of 31 metabolic pathways were consistently associated with S. mansoni
infection in WT mice by both MaAsLin2 (p<0.05; FDR q-value>0.05 for all features) and
LEfSe [Linear Discriminant Analysis (LDA) score (log)>2]. In particular, 21 pathways were
overrepresented in the gut microbiomes of WT Sm+, and 10 in the microbiomes of WT Sm(S5 Table). In HMA, 50 metabolic pathways were consistently associated with S. mansoni
infection by both MaAsLin2 and LEfSe (S6 Table). Of these, 19 were overrepresented in the
gut microbiomes of HMA Sm+ mice, and 31 in the microbiomes of HMA Sm-. In both mouse
lines, most of the metabolic pathways altered by S. mansoni infection could be grouped into
three functional categories: (i) biosynthesis, (ii) degradation/utilization/assimilation and/or
(iii) generation of precursor metabolites and energy (S5 and S6 Tables). Eleven metabolic pathways displayed significant changes with S. mansoni infection in both WT and HMA (S7
Table); of these, 3 were consistently altered by infection in both WT and HMA, including a
pathway for the biosynthesis of L-tryptophan (i.e., TRPSYN-PWY) (Fig 4B). Moreover, the gut
microbiomes of both WT Sm+ and HMA Sm+ displayed an enhanced (predicted) ability to
produce selected SCFAs, albeit via different metabolic pathways (Fig 4C). Together, these findings point towards a likely functional link between Schistosoma infection and the production
of selected microbial metabolites as result of the dynamic cross-kingdom interaction in the
gut.

Enhanced potential for L-tryptophan biosynthesis and butyrate production
in both schistosome-infected WT and HMA mice
S. mansoni infection was shown to significantly impact gut microbial amino acid metabolism
in both WT and HMA hosts (S5 and S6 Tables), although several pathways changed in
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Fig 4. Impact of Schistosoma mansoni infection on the fecal metabolic profiles of wild type (WT) and human-microbiota-associated
(HMA) mice. Principal Component Analysis (PCA) according to infection status (A) and infection-associated changes in gut metagenome
capacity for tryptophan biosynthesis (B) and short-chain fatty acids production (C). Asterisks indicate significant differences in pathway
abundance between S. mansoni-infected (Sm+) and uninfected controls (Sm-) of each mouse line by both MaAsLin2 (p<0.05) and LEfSe [LDA
score (log) > 2]. Hashtags indicate significant differences in the contribution of selected bacterial species to the overrepresentation of
corresponding pathway(s) (MaAsLin2, p<0.05). Full pathway denominations: TRPSYN-PWY = L-tryptophan biosynthesis;
ANAEROFRUCAT-PWY = homolactic fermentation; PWY-5022 = 4-aminobutanoate degradation V; P461-PWY = hexitol fermentation to
lactate, formate, ethanol and acetate; PWY-5676 = acetyl-CoA fermentation to butanoate II; PWY-5100 = pyruvate fermentation to acetate and
lactate II; PWY-5677 = succinate fermentation to butanoate.
https://doi.org/10.1371/journal.pntd.0010878.g004

opposite directions following parasite colonization in each mouse line (S7 Fig). In particular,
‘superpathway of L-serine and glycine biosynthesis I’ (SER-GLYSYN-PWY), ‘L-ornithine biosynthesis II’ (ARGININE-SYN4-PWY), and ‘GABA shunt’ (GLUDEG-I-PWY; a pathway for
L-glutamate degradation) were enriched in the microbiome of WT Sm+ compared with WT
Sm-, and in HMA Sm- compared with HMA Sm+. In addition, ‘L-methionine biosynthesis III’
(HSERMETANA-PWY) and ‘L-arginine biosynthesis II (acetyl cycle)’ (ARGSYNBSUB-PWY)
were significantly enriched in HMA Sm+ (S7 Fig). In contrast, ‘L-tryptophan biosynthesis’
(TRPSYN-PWY) was consistently linked to S. mansoni infection in both WT and HMA mice
(Fig 4B). Expansion of this pathway in WT Sm+ mice was linked to two Lachnospiraceae bacteria (i.e., A4 and 10 1) as well as to Bacteroides vulgatus; nonetheless, the individual contribution of these bacteria to the overrepresentation of the pathway was not statistically significant
(Fig 4B). In HMA, in contrast, expansion of TRPSYN-PWY following infection was significantly linked to B. vulgatus, together with other low abundant bacteria (Fig 4B).
The microbial metabolism of amino acids plays key roles in the maintenance of gut barrier
integrity and immune homeostasis [40]. For instance, polyamines derived from arginine and
ornithine metabolism enhance gut barrier function by inducing overexpression of tight junction proteins and reducing inflammation [41–43]. For these reasons, an enhanced metabolism
of these amino acids by the gut microbiome has been linked to a ‘healthy’ gut [44,45]. Given
the differences detected between WT vs. HMA hosts in infection-associated alterations in arginine/ornithine/polyamine metabolism (S7 Fig and S5 and S6 Tables), caution is warranted
when discussing any role(s) of these amino acids and corresponding metabolites in the context
of schistosomiasis. However, the enhanced capacity for bacterial tryptophan biosynthesis
detected in both rodent lines following S. mansoni infection may suggest a likely link between
parasite infection and luminal production of this essential amino acid that, under physiological
conditions, is mainly of dietary acquisition [46]. Both host- and microbiota-derived tryptophan metabolites are involved in the regulation of several host functions, including immune
regulation by RORγt(+) IL-22(+) type 3 innate lymphoid cells (ILC3s) and maintenance of gut
barrier function [46,47]. Hence, the enrichment of the ‘L-tryptophan biosynthesis’ pathway in
the gut microbiomes of both WT and HMA mice following S. mansoni infection raises the
question of whether this might serve as a compensatory mechanism to counteract local tissue
damage caused by the migration of schistosome eggs through the intestinal wall. Future studies, including targeted perturbation of the ‘L-tryptophan biosynthesis’ pathway [e.g., 48] in the
context of schistosome infection are needed to address this question.
Only a few gut resident bacteria, including selected species of the phyla Firmicutes and Bacteroidetes, are currently known to metabolize luminal tryptophan into indole and its derivatives [49]; these molecules may promote intestinal epithelial cell (IEC) renewal, barrier
integrity, and maintenance of immune homeostasis via the activation of aryl hydrocarbon
receptor (AhR) signaling in intestinal epithelial and mucosal immune cells [46,47]. Our analysis did not detect any pathway for tryptophan degradation; nevertheless, significant expansions
of the tryptophan metabolizing species P. distasonis, L. reuteri and L. johnsonii [49] were
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observed in the gut of WT mice following infection by S. mansoni (Fig 3C). Interestingly, populations of L. reuteri, but not of L. johnsonii, are known to expand in response to increased
luminal tryptophan availability, and catabolize tryptophan into indole derivatives via aromatic
amino acid aminotransferase [50]. In turn, L. reuteri mediates reprograming of intraepithelial
CD4+ T cells into immunoregulatory CD4+CD8αα+ T cells via production of indole derivatives and activation of AhR signaling [51], and induces innate IL-22 production in the mouse
gut by ILC3s, thus promoting gut barrier function [50]. IL-22 regulates production of antimicrobial peptides (AMPs) in the gut [52]. Strikingly, antibody-mediated neutralization of this
cytokine was associated with the expansion of gut populations of B. acidifaciens in a murine
model of Salmonella infection, an effect that was linked to an altered production of IL-22-regulated AMPs (i.e., Reg3β) [20]. In a different study, however, IL-22-mediated AMP responses
led to a significant reduction of Bacteroides and the expansion of Lactobacillus [53]. Our finding of a concomitant expansion of B. acidifaciens along with several tryptophan metabolizing
bacteria (i.e., P. distasonis, L. reuteri and L. johnsonii) in the gut of WT Sm+ reveals a complex
scenario, where both parasite-specific- and microbiota-modulated-immunity are likely to
influence populations of selected microbial species. Future studies addressing the contribution
of selected members of the gut microbiome to the local immune response during intestinal
schistosomiasis will assist to disentangle the intricate interplay between parasite infection,
these bacteria, and host immunity.
In addition to tryptophan metabolites, microbiota-derived SCFAs, and butyrate in particular, are involved in the regulation of AhR and its target genes in both liver and intestine
[54,55]. In addition, butyrate promotes gut barrier integrity by modulating transcription factors in IECs (i.e., activating HIF1, STAT3 and SP1, and inhibiting NF-kB) and mediates antiinflammatory functions by signaling on innate and adaptive immune cells [19]. Metabolic
pathways involved in the production of butyrate were overrepresented in the gut microbiome
of both WT and HMA mice following infection with S. mansoni. In particular, the pathways
‘acetyl-CoA fermentation to butanoate II’ (PWY-5676) and ‘4-aminobutanoate degradation V’
(PWY-5022) were enriched in the gut microbiomes of HMA Sm+ and WT Sm+ mice, respectively, compared to their uninfected counterparts (Fig 4C and S5 and S6 Tables). The gut
microbiome of WT Sm+ was also enriched in the ‘GABA shunt’ pathway, whose products (i.e.,
4-aminobutanoate and succinate) are metabolized to butyrate through the ‘4-aminobutanoate
degradation V’ pathway (cf. S5 Table). Furthermore, the gut microbiomes of infected animals
of both host lines displayed enhanced potential for production of acetate and/or lactate, that
are both key substrates for butyrate-producing bacteria [13,14,56,57]. In particular, the pathways ‘pyruvate fermentation to acetate and lactate II’ (PWY-5100) and ‘acetylene degradation
(anaerobic)’ (P161-PWY) were enriched in HMA Sm+, whereas ‘homolactic fermentation’
(ANAEROFRUCAT-PWY) was overrepresented in WT Sm+ (Fig 4C and S5 and S6 Tables).
Specific bacteria linked to these functions remained largely unclassified both in WT and HMA
mice (Fig 4C). Nevertheless, a significant contribution of Flavonifractor plautii to PWY-5676
was observed in HMA Sm+, whereas Dorea sp CAG 317, F. plautii and Hungatella hathewayi
were significantly linked to the overrepresentation of PWY-5100 in the gut of the same animals
(Fig 4C).
Additional pathways related to SCFA production were underrepresented in both WT Sm+
and HMA Sm+, compared to uninfected counterparts. In particular, the pathways ‘hexitol fermentation to lactate, formate, ethanol and acetate’ (P461-PWY) and ‘succinate fermentation
to butanoate’ (PWY-5677) were enriched in the gut microbiomes of WT Sm- and HMA Sm-,
respectively (S5 and S6 Tables). Nonetheless, these pathways were comparatively less abundant
than those involved in the same metabolic processes (i.e., lactate/acetate and butyrate biosynthesis) and that were overrepresented in Sm+ of the corresponding host line (Fig 4C).
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Metabolic profiling of biofluids had already revealed alterations of gut microbial metabolites in mice infected with S. mansoni, including SCFAs [58,59]. In particular, acetate, propionate and butyrate were depleted in urine samples of infected mice at 7 weeks post-infection,
which suggested either a reduced production of these SCFAs by gut bacteria or an increased
utilization of these metabolites by the vertebrate host [58]. In support of the latter hypothesis,
in a separate study, significantly increased levels of propionate were detected in feces of Sm+
between 7 and 9 weeks post-infection, although no statistically significant differences in butyrate levels were detected between infected mice and uninfected controls [59]. The discrepancies between data from our study and that by Li et al. [59] might be linked to differences
between mouse strains [C57BL/6 vs. NMRI, respectively] and/or other factors known to affect
the composition of the host gut microbiota, such as age or diet [18]. Nonetheless, observations
from both our study and that by Li et al. [59]. support a link between S. mansoni infection and
enhanced SCFAs biosynthesis in the rodent gut.

Schistosomiasis may be associated with reduced horizontal gene transfer
within the microbiota of HMA mice
The relative abundances of the top 10,000 functionally annotated gene families identified by
HUMAnN3 in at least 5 metagenomes of either HMA or WT were compared between Sm+
and Sm- by MaAsLin2 and LEfSe. The substantial differences in the microbiomes of WT mice
between the two independent experiments performed (‘B1’ and ‘B2’; cf. Materials and Methods) impaired the optimal fitting of the linear model (LM) calculated by MaAsLin2 to determine associations between gene family abundances and S. mansoni infection in these mice.
Therefore, in order to overcome this technical limitation, the MaAsLin2 output was compared
with that obtained by LEfSe; this approach led to the identification of 3 gene families whose
relative abundances were altered by S. mansoni infection according to both MaAsLin2
(q<0.05) and LEfSe [LDA score (log)>2]. These gene families, enriched in the gut microbiome
of WT Sm+ mice compared to WT Sm-, encoded for 2 proteins involved in chromosome segregation (i.e., chromosome partitioning and ParB-like partition proteins) and a TraG-like protein involved in conjugative plasmid transfer (S8 Table). A total of 6 and 62 gut microbial gene
families were enriched in HMA Sm+ and HMA Sm-, respectively, by both MaAsLin2 (q<0.01)
and LEfSe [LDA score (log)>2)] (S9 Table). Notably, amongst the latter, there were several
families with roles in plasmid biology, including genes encoding proteins involved in conjugative plasmid transfer (e.g., MobA, MobB and MobC, amongst others), plasmid recombination
(i.e., plasmid recombination enzyme family proteins), initiation of plasmid replication and
plasmid copy control (e.g., protein involved in initiation of plasmid replication and RepA)
(S9 Table).
Plasmids mediate horizontal gene transfer (HGT) between bacteria [60]. A recent study has
revealed that HGT occurs frequently within individual human gut microbiomes, although frequency is higher in industrialized urban populations than in non-industrialized rural communities [61]. The specific factors responsible for such differences are currently unknown;
however, it has been speculated that alterations in the gut ecosystem linked, for instance, to the
dramatic changes in dietary and sanitation habits experienced throughout the industrialization
process, rather than variations in bacterial species composition, are likely to be held accountable [61]. Improved sanitation in tropical and subtropical impoverished areas of the world has
led to a significantly reduced risk of infection with many parasitic worms, including Schistosoma spp. [62]. Hence, the significance of our observation that several gene families related to
regulation of plasmid transfer were underrepresented in the gut of HMA Sm+ mice is worth
exploring. It is well established that, within the gut microbiota, antimicrobial resistance
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(AMR) genes are maintained and exchanged via HGT among bacterial communities [63]. A
recent report showed no significant association between gut microbiota, AMR genes and urogenital schistosomiasis in preschool-aged children [64]. However, further studies are needed
to determine whether hepato-intestinal schistosomiasis might represent an additional factor
limiting HGT, thus impacting on the distribution of AMR genes in the host gut. Interestingly,
we identified a number of gene families related to resistance against several classes of antibiotics, including beta-lactams, fluoroquinolones, tetracyclines, aminoglycosides, macrolides and
chloramphenicol (S10 Table) and detected significant differences (by MaAsLin2 only) in the
abundance of 9 families linked to AMR in HMA mice (S9 Table). In particular, these gene families, all of which were significantly associated with the gut microbiome of HMA Sm- mice,
encoded for proteins involved in resistance against beta-lactams (4 families), macrolides (3
families), tetracyclines and chloramphenicol (1 family each).

Concluding remarks
In this study, we investigated the impact of S. mansoni infection on the gut microbial composition and predicted functions of two mouse lines with significant differences in their baseline
gut microbial communities (i.e., WT and HMA). Comparisons of gut microbial functional
profiles between Sm+ and Sm- mice revealed infection-associated alterations in both hosts,
some of which were consistently associated with worm colonization, whereas others displayed
opposite trends in each infection model. Occurrence of consistent microbiome alterations in
response to infection suggest a fine crosstalk between S. mansoni and the host gut microbiome.
In particular, our findings support the hypothesis that gut microbial responses to S. mansoni
infection might involve enhanced production of tryptophan metabolites and butyrate, and
subsequent activation of AhR signaling and further butyrate-regulated pathways, in order to
limit helminth-induced tissue damage. These findings offer a novel and intriguing perspective
on the role(s) of the host gut microbiome in the pathophysiology of schistosomiasis, including
its likely contribution to Schistosoma egg-induced intestinal pathology and inflammation in
infected hosts [4,6]. Indeed, together with those previous reports, our current results point
toward a likely dual role of the gut microbiome in the pathophysiology of schistosomiasis,
where intestinal bacteria may contribute to egg-associated intestinal pathology while, simultaneously, protect the host from excessive tissue damage. This data may open new avenues
towards the discovery of tentative bacterial targets for innovative control strategies, that are
desperately needed for this neglected tropical disease. In addition, our preliminary observation
that schistosomiasis mansoni might impact HGT in the vertebrate gut microbiota offers an
intriguing insight into helminth-microbiota relationships, and calls for future investigations
aimed to assess the role(s) that helminth infections might play in gene flow and spread of
AMR in both rodent models and natural hosts.

Materials and methods
Ethics statement
The life cycle of S. mansoni (NMRI strain) was maintained at the Wellcome Sanger Institute
(WSI) by breeding and infecting susceptible intermediate (Biomphalaria glabrata snails) and
definitive hosts (female TO mice). All experimental infections and regulated procedures
described in this study were approved by the Animal Welfare and Ethical Review Body
(AWERB) of WSI. All experiments were conducted under Home Office Project Licenses (Procedure Project License—PPL) No. P77E8A062 held by Gabriel Rinaldi, and No. P6D3B94CC
held by Trevor D. Lawley. The AWERB is constituted as required by the UK Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012.
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Experimental procedures
Detailed methods for generating and breeding HMA mice, production of S. mansoni infective
stages, experimental infections and parasitological procedures are available from Cortés et al.
[8]. Briefly, 200 μl homogenates obtained from fresh feces from a healthy human donor were
administered to 5 male and 5 female C57BL/6 germ-free mice by oral gavage once a week, for
3 weeks. Mice were subsequently set up as breeding pairs in a decontaminated positive pressure isolator. HMA mice used in this study belonged to the fourth generation of breeding animals; these were removed from the isolator in sealed ISOcages and maintained on a positive
pressure ISOrack (Tecniplast) for use in the experiments described below. A total of 8 HMA
and 8 WT mice (female C57BL/6, bred at the WSI) were infected percutaneously with 80 S.
mansoni cercariae (Sm+), as described previously [65] and maintained for 50 days with access
to food and water ad libitum. Six HMA and WT mice, respectively, were kept uninfected and
used as negative controls (Sm-). Two independent experiments were performed (identified as
‘B1’ and ‘B2’, respectively) using identical procedures as described above. Experiment B1
included 5 Sm+ and 3 Sm- of each HMA and WT, while experiment B2 included 3 Sm+ and 3
Sm- of each HMA and WT [8]. All mice were euthanized 50 days post-infection, and adult
worms recovered from Sm+ mice via portal perfusion [65]. Control Sm- mice were perfused as
the infected animals. Fecal pellets were collected directly from the colons of individual mice at
necropsy; pellets were transferred to sterile tubes, snap frozen on dry ice, and stored at -80˚C
until DNA isolation, which was performed within 3 weeks from sample collection.

DNA extraction and shotgun metagenomics sequencing
Genomic DNA was isolated from a total of 28 colonic content samples and 4 no-DNA template negative controls from both independent experiments, using the PowerSoil DNA Isolation Kit (QIAGEN) according to manufacturers’ instructions. DNA was prepared and
sequenced at WSI using the Illumina Hi-Seq platform with library fragment sizes of 200–300
bp and a read length of 100 or 125 bp, as previously described [66].

Bioinformatics analyses, statistics and reproducibility
WGS reads were subjected to quality and adapter trimming using Trim Galore (version 0.4.0) using
default parameters, and paired reads of <20 bp for at least one of the two sequences were removed
(https://github.com/FelixKrueger/TrimGalore; [67]). Quality-filtered reads were mapped against the
Mus musculus reference genome (GRCm38 assembly) using the BWA-MEM algorithm [68].
Clean reads were mapped against reference bacterial genomes available from GenBank
(S11 Table) and, for each sample, microbial community composition was defined based on the
relative abundance of each genome displaying breadth coverage �1% and depth coverage
>0.01X (S1 Table); the gut microbial communities of Sm- and Sm+ HMA and WT mice were
compared using the online software MicrobiomeAnalyst [69]. In particular, following CSS
data normalization, samples were clustered by PCoA based on Bray-Curtis dissimilarities, and
differences in beta diversity between groups were assessed by Analysis of Similarity (ANOSIM)
[70]. Differences in microbial species richness and Shannon index between groups were
assessed by unpaired t-test. Furthermore, heatmaps displaying Pearson correlation between
community composition and explanatory variables, i.e., mouse line (WT and HMA), infection
status (Sm+ and Sm-) and experiment (B1 and B2) were generated; significant alterations in
the relative abundances of microbial taxa following experimental S. mansoni infection were
determined by LEfSe [71] and Mann-Whitney U test. Occurrence of linear relationships
between the relative abundance (logarithmic) of gut bacterial species significantly impacted by
S. mansoni infection, as well as infection burdens (i.e., worm counts and EPG of liver; cf. [8]),
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was tested by Pearson correlation and the statistical significance of the Pearson correlation
coefficient (r) was assessed by two-tailed t-test.
Functional annotations of gut metagenome data were performed using HUMAnN3 [72],
ran from the biobakery/humann docker container (latest version as of October 2020) using the
Chocophlan nucleotide database and Uniref90 protein database [73]. HUMAnN3 runs the
Metaphlan program as an intermediate step to assign organism-specific functional profiling,
which was performed using the developer-provided MetaPhlAn3 bowtie2 database [17,74].
Additional scripts embedded within HUMAnN3 (humann_rename_table and human_join_table) were used to align gene family descriptions and merge the 128 original output gene family abundance tables into a single table. The HUMAnN3 pipeline also provided MetaCyc [75]
pathway abundance detected per sample. HUMAnN’s default Reads Per Kilobase (RPK) values
for gene family and pathway abundances were transformed into copies per million (CPM)
units using the “humann_renorm_table” script (included in the HUMAnN3 distribution; S10
and S12 Tables) and associations between the predicted functional properties of each metagenome and S. mansoni infection in either HMA and WT mice were assessed by PCA and CCA
using Calypso [76]. Biological pathways and gene families significantly enriched in the metagenomes of either Sm- or Sm+ mice (HMA and WT, respectively) were determined using
MaAsLin2 [77], by applying the LM with default settings (except for the analysis of gene families, prior to which data were log-transformed); potential differences between samples collected in each independent experiment were taken into account by fixing this variable as a
random effect. Furthermore, pathway and gene family relative abundances were compared
between Sm+ and Sm- of each HMA and WT using the LEfSe workflow [71] implemented in
Galaxy (https://huttenhower.sph.harvard.edu/galaxy/), setting the variable “experiment” as
subgroup for comparisons. Both pathway and gene family detection for a given rodent line
was defined when confirmed in at least 5 out of the 14 samples analyzed per line.

Supporting information
S1 Fig. Whole genome sequencing output. (A) Read counts obtained from fecal DNA
extracts of wild type (WT) and human-microbiota-associated (HMA) mice, and negative controls (i.e., no-DNA template; NC); � p<0.05, �� p<0.01 and ns = not significant by post hoc
Dunn’s test. (B) and (C) Base counts prior to (= sequenced) and following quality filtering and
removal of host sequences (= filtered) according to mouse line and infection status, respectively. Differences between groups were assessed by Mann-Whitney U test. Sm+ = Schistosoma
mansoni-infected; Sm- = S. mansoni-uninfected.
(EPS)
S2 Fig. Gut microbiota composition of wild type (WT) and human-microbiota-associated
(HMA) mice. (A) Venn diagram indicating the total number of bacterial species and corresponding genera identified in the metagenomes of WT and/or HMA mice following mapping
of shotgun metagenomic reads against bacterial reference genomes available from the GenBank database. (B) Relative abundances of the 30 most abundant species.
(EPS)
S3 Fig. Gut microbiota composition of wild type (WT) and human-microbiota-associated
(HMA) mice. Relative abundances, per sample, of the 30 most abundant bacterial species.
Samples are hierarchically clustered according to Pearson correlation between species relative
abundances, and explanatory variables are indicated at the top of the figure (i.e., mouse line,
infection status and infection burdens; cf. Fig 1. EPG = eggs per gram).
(PDF)
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S4 Fig. Gut bacterial functional profiles in wild type (WT) vs. human-microbiota-associated (HMA) mice. Venn diagram indicating the total number of bacterial metabolic pathways
identified by HUMAnN3 in the gut metagenomes of at least five samples of WT and/or HMA
mice.
(EPS)
S5 Fig. Gut bacterial alpha diversity in Schistosoma mansoni infected (Sm+) and uninfected
(Sm-) mice. Shannon diversity and species richness in Sm+ and Sm- samples of (A) wild type
(WT) and (B) human-microbiota-associated (HMA) mice. Asterisks indicate significant differences between groups determined by unpaired t-test: � p<0.05.
(EPS)
S6 Fig. Fecal metabolic profiles of wild type (WT) mice. Principal Component Analysis
(PCA) of the fecal metabolic profiles of WT mice according to experiment and infection status
(Sm+ = Schistosoma mansoni-infected; Sm- = uninfected controls).
(EPS)
S7 Fig. Gut bacterial capacity for amino acid metabolism in wild type (WT) and humanmicrobiota-associated (HMA) mice. For each mouse line, only differentially abundant pathways between S. mansoni infected (Sm+) and uninfected (Sm-) animals (cf. S5 and S6 Tables)
are shown.
(EPS)
S1 Table. List of bacterial genomes detected in fecal samples of wild type (WT) and/or
human-microbiota-associated (HMA) mice by mapping of reads against reference bacterial genomes available from the GenBank database. Only genomes displaying mean breadth
coverage �1% and mean depth coverage >0.01X were considered in each mouse line.
nd = not detected.
(XLSX)
S2 Table. Metabolic pathways. (A) Metabolic pathways identified in at least 5 fecal samples of
wild type (WT) and/or human-microbiota-associated (HMA) mice by HUMAnN3. (B) Metabolic pathways identified only in WT samples, stratified by known and unclassified organisms.
(C) Metabolic pathways identified only in HMA samples, stratified by known and unclassified
organisms.
(XLSX)
S3 Table. Bacterial species in wild type (WT) and human-microbiota-associated (HMA)
mice. Results of LEfSe and Mann-Whitney U test applied to the identification of differentially
abundant bacterial species between the gut microbial communities of Schistosoma mansoniinfected (Sm+) and uninfected (Sm-) WT and HMA mice.
(XLSX)
S4 Table. Correlation between gut bacterial abundance and infection burdens. Pearson correlation between the relative abundance of gut bacterial species significantly impacted by Schistosoma mansoni infection in wild type (WT) and human-microbiota-associated (HMA) mice
(cf. Fig 3) and infection burdens (i.e., worm counts and eggs per gram (EPG) of liver; cf. [8]).
(XLSX)
S5 Table. Metabolic pathways in wild type (WT) mice. Differentially abundant metabolic
pathways between the gut microbiomes of Schistosoma mansoni-infected (Sm+) and -uninfected (Sm-) WT mice by MaAsLin2 (p<0.05) and/or LEfSe [LDA score (log)>2]. For each
pathway, mean abundance and standard deviation (SD), fold change between groups, and
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functional classification according to MetaCyc database are provided. Fold change
<0 = overrepresented in Sm-; fold change >0 = overrepresented in Sm+.
(XLSX)
S6 Table. Metabolic pathways in human-microbiota-associated (HMA) mice. Differentially
abundant metabolic pathways between the gut microbiomes of Schistosoma mansoni-infected
(Sm+) and -uninfected (Sm-) HMA mice by MaAsLin2 (p<0.05) and/or LefSe [LDA score
(log)>2]. For each pathway, mean abundance and standard deviation (SD), fold change
between groups, and functional classification according to MetaCyc database are provided.
Fold change <0 = overrepresented in Sm-; fold change >0 = overrepresented in Sm+.
(XLSX)
S7 Table. Metabolic pathways in both wild type (WT) and human-microbiota-associated
(HMA) mice. Differentially abundant metabolic pathways [MaAsLin2 p<0.05 and LefSe LDA
score (log)>2] between the gut microbiomes of both WT and HMA mice infected by Schistosoma mansoni (Sm+) and matched uninfected controls (Sm-). For each pathway, functional
classification according to MetaCyc database and fold change between infected and uninfected
animals of each line are indicated. Fold change <0 = overrepresented in Sm-; fold change
>0 = overrepresented in Sm+.
(XLSX)
S8 Table. Gene families in wild type (WT) mice. Differentially abundant gene families
between the gut microbiomes of Schistosoma mansoni-infected (Sm+) and uninfected (Sm-)
WT mice, by MaAsLin2 (q<0.05) and/or LefSe [LDA score (log)>2]. For each family, mean
relative abundance, standard deviation (SD) and fold change between Sm- and Sm+ are provided.
(XLSX)
S9 Table. Gene families in human-microbiota-associated (HMA) mice. Differentially abundant gene families between the gut microbiomes of Schistosoma mansoni-infected (Sm+) and
-uninfected (Sm-) HMA mice, by MaAsLin2 (q<0.01) and/or LefSe [LDA score (log)>2]. For
each family, mean relative abundance, standard deviation (SD) and fold change between Smand Sm+ are provided.
(XLSX)
S10 Table. Gene family abundances. Relative abundances (in CPM; copies per million) of gene
families computed by HUMAnN3 at community level for each sample included in this study.
(XLS)
S11 Table. Mapping results. Results of mapping of whole genome shotgun sequencing reads
against reference bacterial genomes available from GenBank.
(XLSX)
S12 Table. Metabolic pathway abundance. Relative abundances [in CPM (copies per million)
and for each sample included in this study] of metabolic pathways identified by HUMAnN3 at
community level using gene abundances along with the structure of the pathway (based on
MetaCyc pathway definitions).
(XLSX)
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Francés R, et al. Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in
obese mice. Gut Microbes 2021; 13: 1–20. https://doi.org/10.1080/19490976.2020.1865706 PMID:
33499721

27.

Neff CP, Rhodes ME, Arnolds KL, Collins CB, Donnelly J, Nusbacher N, et al. Diverse intestinal bacteria
contain putative zwitterionic capsular polysaccharides with anti-inflammatory properties. Cell Host
Microbe 2016; 20: 535–47. https://doi.org/10.1016/j.chom.2016.09.002 PMID: 27693306

28.

Tsou AM, Goettel JA, Bao B, Biswas A, Kang YH, Redhu NS, et al. Utilizing a reductionist model to
study host-microbe interactions in intestinal inflammation. Microbiome 2021; 9: 215. https://doi.org/10.
1186/s40168-021-01161-3 PMID: 34732258

29.

Biggs MB, Medlock GL, Moutinho TJ, Lees HJ, Swann JR, Kolling GL, et al. Systems-level metabolism
of the altered Schaedler flora, a complete gut microbiota. ISME J 2017; 11: 426–38. https://doi.org/10.
1038/ismej.2016.130 PMID: 27824342

PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0010878 October 24, 2022

22 / 25

PLOS NEGLECTED TROPICAL DISEASES

The gut microbiome of Schistosoma-infected wildtype vs. microbiota-humanised mice

30.

Wu T-R, Lin C-S, Chang C-J, Lin T-L, Martel J, Ko Y-F, et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 2019; 68: 248–62. https://doi.org/10.1136/gutjnl-2017-315458 PMID: 30007918

31.

Lai H-C, Lin T-L, Chen T-W, Kuo Y-L, Chang C-J, Wu T-R, et al. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut 2022; 71: 309–
21. https://doi.org/10.1136/gutjnl-2020-322599 PMID: 33687943

32.

Ezeji JC, Sarikonda DK, Hopperton A, Erkkila HL, Cohen DE, Martinez SP, et al. Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and
probiotic roles in human health. Gut Microbes 2021; 13: 1922241. https://doi.org/10.1080/19490976.
2021.1922241 PMID: 34196581

33.

Cortés A, Peachey L, Scotti R, Jenkins TP, Cantacessi C. Helminth-microbiota cross-talk–A journey
through the vertebrate digestive system. Mol Biochem Parasitol 2019; 233: 111222. https://doi.org/10.
1016/j.molbiopara.2019.111222 PMID: 31541662

34.

Di Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T. Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol 2016; 69: 187–203. https://doi.org/10.1136/jclinpath-2015-202976
PMID: 26578541

35.

Vitetta L, Vitetta G, Hall S. Immunological tolerance and function: associations between intestinal bacteria, probiotics, prebiotics, and phages. Front Immunol 2018; 9: 2240. https://doi.org/10.3389/fimmu.
2018.02240 PMID: 30356736

36.

Schreiber O, Petersson J, Phillipson M, Perry M, Roos S, Holm L. Lactobacillus reuteri prevents colitis
by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. Am J Physiol
Gastrointest Liver Physiol 2009; 296: G534–542. https://doi.org/10.1152/ajpgi.90470.2008 PMID:
19147805

37.

Dicksved J, Schreiber O, Willing B, Petersson J, Rang S, Phillipson M, et al. Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One
2012; 7: e46399. https://doi.org/10.1371/journal.pone.0046399 PMID: 23029509

38.

Zhang Y, Mu T, Yang Y, Zhang J, Ren F, Wu Z. Lactobacillus johnsonii attenuates Citrobacter rodentium-induced colitis by regulating inflammatory responses and endoplasmic reticulum stress in mice. J
Nutr 2021; 151: 3391–9. https://doi.org/10.1093/jn/nxab250 PMID: 34383918

39.

Reynolds LA, Smith KA, Filbey KJ, Harcus Y, Hewitson JP, Redpath SA, et al. Commensal-pathogen
interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes 2014; 5: 522–32. https://doi.org/10.4161/gmic.32155 PMID: 25144609

40.

Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016; 16:
341–52. https://doi.org/10.1038/nri.2016.42 PMID: 27231050

41.

Zhang M, Wang H, Tracey KJ. Regulation of macrophage activation and inflammation by spermine: a
new chapter in an old story. Crit Care Med 2000; 28: N60–6. https://doi.org/10.1097/00003246200004001-00007 PMID: 10807317

42.

Chen J, Rao JN, Zou T, Liu L, Marasa BS, Xiao L, et al. Polyamines are required for expression of Tolllike receptor 2 modulating intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol
2007; 293: G568–76. https://doi.org/10.1152/ajpgi.00201.2007 PMID: 17600044

43.

Liu L, Guo X, Rao JN, Zou T, Xiao L, Yu T, et al. Polyamines regulate E-cadherin transcription through
c-Myc modulating intestinal epithelial barrier function. Am J Physiol Cell Physiol 2009; 296: C801–10.
https://doi.org/10.1152/ajpcell.00620.2008 PMID: 19176757

44.

Qi H, Li Y, Yun H, Zhang T, Huang Y, Zhou J, et al. Lactobacillus maintains healthy gut mucosa by producing L-Ornithine. Commun Biol 2019; 2: 171. https://doi.org/10.1038/s42003-019-0424-4 PMID:
31098404

45.

Pruss KM, Enam F, Battaglioli E, DeFeo M, Diaz OR, Higginbottom SK, et al. Oxidative ornithine metabolism supports non-inflammatory C. difficile colonization. Nat Metab 2022; 4: 19–28. https://doi.org/10.
1038/s42255-021-00506-4 PMID: 34992297

46.

Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 2018; 23: 716–24. https://doi.org/10.1016/j.chom.2018.05.003 PMID:
29902437

47.

Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol 2018; 8: 13. https://doi.org/10.3389/fcimb.
2018.00013 PMID: 29468141

48.
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